Oncology News - Doctors Lounge

Radiation plus hormone therapy increases survival in prostate cancer.

Sat, 04 Oct 2008 00:07:20 PST

Radiotherapy added to anti-androgen hormone therapy reduces the risk of dying of prostate cancer by 50 percent. [ASTRO].

Study finds association between hepatitis B and pancreatic cancer

Fri, 03 Oct 2008 23:34:47 PST

Past hepatitis B infection was twice as prevalent in patients with pancreatic cancer as in healthy people. [J Clin Oncol].

Anti-inflammatory drugs may mask prostate cancer marker (PSA)

Fri, 12 Sep 2008 14:39:23 PST

Regular use of aspirin and ibuprofen may reduce serum levels of PSA altering the detection of prostate cancer. [Cancer].

Risk of breast cancer mutations underestimated for Asian women

Fri, 12 Sep 2008 13:39:15 PST

Study suggests more Asian American women may need to be tested for BRCA mutations. J Clin Oncol.

Galiximab - rituximab in previously untreated follicular lymphoma

Sat, 07 Jun 2008 18:26:31 PST

The Cancer and Leukemia Group B announced data from a phase II clinical trial showing that 70 percent response rate.

Model predicts renal cancer disease free survival at 12 years

Tue, 03 Jun 2008 10:26:27 PST

Unique statistical model that predicts the probability of a patient being cancer free 12 years after initial surgical treatment. J Urol.

Cellular atypia of the breast in at least 3 sites is more predictive of cancer

Sat, 30 Jun 2007 20:35:19 PST

Women with at least 3 sites of cellular atypia in the breast are nearly 8 times more likely to develop breast cancer - J Clin Oncol.

Cervarix may provide broader protection against cervical cancer

Thu, 28 Jun 2007 19:27:13 PST

Vaccine provides effective protection against HPV types 16 and 18 infections as well as other strains - Lancet.

A faster way to recover from chemotherapy and marrow transplant

Thu, 21 Jun 2007 09:38:02 PST

Discovery in zebrafish could lead to new ways of boosting patients blood cells according to a Nature study - Nature.

Femara (letrozole) offers new hope for ovarian cancer patients

Thu, 21 Jun 2007 09:35:10 PST

Hormone therapy can extend life in ovarian cancer patients, giving women a new alternative to chemotherapy - Clin Cancer Res.

Family structure size could affect breast cancer risk prediction

Thu, 21 Jun 2007 09:31:53 PST

Finding may challenge accuracy of some breast cancer prediction models that do not include family structure - JAMA.

MRI of opposite breast necessary for recent breast cancer diagnosis

Wed, 28 Mar 2007 09:20:38 PST

MRI detected cancer in the opposite breast in 3.1 percent of patients with newly diagnosed breast cancer.

Triple negative breast cancers linked to the young - minorities

Mon, 26 Mar 2007 08:13:47 PST

More aggressive breast cancer common among younger women who are African American and Hispanic.

Few surgeons refer breast cancer patients for reconstruction

Mon, 26 Mar 2007 08:08:45 PST

44 percent of surgeons do not refer their breast cancer patients to a plastic surgeon prior to the initial surgery.

FDA approves Tykerb - Xeloda for advanced breast cancer patients

Fri, 16 Mar 2007 08:44:16 PST

The combination is indicated for HER2 positive women who have received prior therapy including Herceptin.

Racial disparities in prostate cancer due to lack of care

Mon, 12 Mar 2007 09:17:43 PST

Health disparities in prostate cancer for African Americans stem from lack of care, not lack of knowledge.

Antibody PET identifies kidney cancers requiring surgery

Thu, 08 Mar 2007 17:02:26 PST

Positron Emission Tomography (PET) using a radiolabeled antibody accurately identifies clear cell renal carcinoma.

CT screening increases lung cancer diagnosis but not survival

Thu, 08 Mar 2007 16:57:14 PST

CT scans for smokers increases risks and do not cut lung cancer deaths - study shows.

Pool of cancer genes appears larger than previously thought

Thu, 08 Mar 2007 16:52:26 PST

Largest genome study of cancer types finds much more mutations than previously thought.

Arimidex switch after tamoxifen improves breast cancer survival

Tue, 21 Nov 2006 20:01:38 PST

Switching to anastrozole after 2 to 3 years of adjuvant tamoxifen improves survival in breast cancer patients.